Want to see JP:3349 full AI Analyst Report?
3349 Stock Chart & Stats
¥6577.00
¥227.00(3.56%)
At close: 4:00 PM EDT
¥6577.00
¥227.00(3.56%)
Day’s Range― - ―
52-Week Range¥5,615.00 - ¥8,121.00
Previous CloseN/A
Volume514.70K
Average Volume (3M)402.69K
Market Cap
¥520.82B
Enterprise Value¥544.51B
Total Cash (Recent Filing)¥61.34B
Total Debt (Recent Filing)¥78.48B
Price to Earnings (P/E)15.6
Beta-0.07
Next Earnings
Jan 08, 2027EPS Estimate
83.58Next Dividend Ex-DateN/A
Dividend Yield1.3%
Share Statistics
EPS (TTM)404.32
Shares Outstanding80,001,600
10 Day Avg. Volume464,800
30 Day Avg. Volume402,693
Financial Highlights & Ratios
PEG Ratio4.18
Price to Book (P/B)1.63
Price to Sales (P/S)0.42
P/FCF Ratio-39.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)404.16
Revenue Forecast (FY)¥1.19T
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSustained revenue expansion indicates continued demand for the company’s medicines, health products, and retail distribution services. Although recent growth moderated, the multi-year increase provides a durable base for operating scale, customer reach, and continued participation in healthcare consumption trends.
Conservative Balance SheetLow leverage and a consistently expanding equity base give COSMOS Pharmaceutical meaningful financial resilience. This structure reduces dependence on debt financing, supports investment through changing conditions, and preserves flexibility for store, inventory, or business expansion over the coming quarters.
Positive Operating Cash FlowPositive and improving operating cash flow shows that the business does generate cash from its ongoing operations. This provides an important internal funding source for working capital and investment, even though the weaker conversion rate means the quality and consistency of that cash generation require monitoring.
Bears Say
Weak Cash ConversionWeak conversion of reported earnings into operating cash suggests that profits are not consistently translating into readily available funds. This can limit internally funded growth and reduce flexibility, particularly if working-capital needs remain elevated while the company continues expanding.
Mostly Negative Free Cash FlowRepeated negative free cash flow indicates that operating cash has not consistently covered investment and other cash demands. Even with positive earnings, this pattern can constrain financial flexibility, increase reliance on the balance sheet, and make sustained expansion more dependent on disciplined capital allocation.
Modest And Pressured MarginsModest profitability leaves less room to absorb higher costs or competitive pricing pressure than a higher-margin business would have. The slight decline in net margin also suggests that revenue growth is not fully converting into earnings improvement, which may limit durable profit compounding.
COSMOS Pharmaceutical Corporation News
3349 FAQ
What was COSMOS Pharmaceutical Corporation’s price range in the past 12 months?
COSMOS Pharmaceutical Corporation lowest stock price was ¥5615.00 and its highest was ¥8121.00 in the past 12 months.
What is COSMOS Pharmaceutical Corporation’s market cap?
COSMOS Pharmaceutical Corporation’s market cap is ¥520.82B.
When is COSMOS Pharmaceutical Corporation’s upcoming earnings report date?
COSMOS Pharmaceutical Corporation’s upcoming earnings report date is Jan 08, 2027 which is in 77 days.
How were COSMOS Pharmaceutical Corporation’s earnings last quarter?
COSMOS Pharmaceutical Corporation released its earnings results on Oct 13, 2026. The company reported ¥104.11 earnings per share for the quarter, beating the consensus estimate of ¥102.828 by ¥1.282.
Is COSMOS Pharmaceutical Corporation overvalued?
According to Wall Street analysts COSMOS Pharmaceutical Corporation’s price is currently Overvalued.
Does COSMOS Pharmaceutical Corporation pay dividends?
COSMOS Pharmaceutical Corporation pays a Semiannually dividend of ¥42 which represents an annual dividend yield of 1.3%. See more information on COSMOS Pharmaceutical Corporation dividends here
What is COSMOS Pharmaceutical Corporation’s EPS estimate?
COSMOS Pharmaceutical Corporation’s EPS estimate is 83.58.
How many shares outstanding does COSMOS Pharmaceutical Corporation have?
COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding.
What happened to COSMOS Pharmaceutical Corporation’s price movement after its last earnings report?
COSMOS Pharmaceutical Corporation reported an EPS of ¥104.11 in its last earnings report, beating expectations of ¥102.828. Following the earnings report the stock price went down -2.159%.
Which hedge fund is a major shareholder of COSMOS Pharmaceutical Corporation?
Currently, no hedge funds are holding shares in JP:3349
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, confectionery, beverages, and alcohol; and tobacco and other products. In addition, the company engages in the maintenance and management of buildings and commercial facilities, traffic control, and security contracting activities. It sells its products through retail stores and online. COSMOS Pharmaceutical Corporation was incorporated in 1983 and is headquartered in Fukuoka City, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
Create SD Holdings Co., Ltd.
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―